ELEVEN THERAPEUTICS CORP
Unleashing the power of RNA to create precise, durable therapeutics.
ENCINITAS, United States · Founded 2022 · $22.0M raised
- Headquarters
- ENCINITAS, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- eleventx.com
- Total Funding
- $22.0M
- Last Round
- $22.0M SeedAug 2022
- Rounds
- 1
About
Eleven Therapeutics is a cross-disciplinary biotech company developing next-generation RNA therapeutics using massively-parallel synthesis and machine learning to map RNA chemical space. Founded in 2020, the company focuses on silencing disease-causing genes to treat respiratory and other diseases, operating hubs in Cambridge UK, Boston, and Tel Aviv. Partners include NIAID, Cambridge University, and Twist Biosciences.
Summary
ELEVEN THERAPEUTICS CORP is a Biotech company based in ENCINITAS, United States, founded in 2022. It has raised $22.0M in total across 1 round, most recently a $22.0M Seed round in Aug 2022. Investors include Bill & Melinda Gates Foundation, Kindred Capital and Innovate UK.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...